Breaking News Instant updates and real-time market news.

MRK

Merck

$62.38

-0.4576 (-0.73%)

12:35
08/08/17
08/08
12:35
08/08/17
12:35

FDA approves Merck request to supplement BLA for Zostavax

According to a letter dated August 3 posted to the FDA website, the agency approved a request made by Merck to supplement its Biologics License Application for its Zostavax vaccine to include safety and immunogenicity data to support the concomitant administration of Zostavax and inactivated influenza vaccines. Reference Link

  • 28

    Aug

  • 22

    Sep

MRK Merck
$62.38

-0.4576 (-0.73%)

07/28/17
RHCO
07/28/17
NO CHANGE
RHCO
Merck, AstraZeneca deal positive, says SunTrust
After Merck (MRK) paid $1.6B upfront for access to Astrazeneca's (AZN) PARP inhibitor, Lynparza and another drug, SunTrust analyst John Boris says that the deal "makes strategic/financial sense and validates the PARP inhibitor class." He adds that the companies are "ideally positioned" to leverage a combination of IO and PARP therapies. The analyst reiterates a $73 price target and a Buy rating on Merck.
07/27/17
JANY
07/27/17
NO CHANGE
Target $107
JANY
Buy
PARP deals may make Clovis more attractive buyout candidate, says Janney
The partnerships announced today between AstraZeneca (AZN) and Merck (MRK) as well as Tesaro (TSRO) and Takeda highlight pharma's willingness to expand on PARP's, Janney analyst Debjit Chattopadhyay tells investors in a research note. Clovis' (CLVS) Rubraca is now the only unencumbered PARP and is "far cheaper" on a relative valuation basis than peer Tesaro, the analyst adds. He believes Clovis could now become a more compelling takeover candidate. Chattopadhyay has a Buy rating on the shares with a $107 price target. The stock in midday trading is up 7%, or $5.90, to $93.33.
07/27/17
FBCO
07/27/17
NO CHANGE
FBCO
Merck unlikely to buy PARP company after Astra deal, says Credit Suisse
Credit Suisse analyst Alethia Young believes Merck (MRK) is unlikely to acquire a PARP inhibitor company like Tesaro (TSRO) or Clovis (CLVS) after inking an immuno-oncology deal with AstraZeneca (AZN).
07/27/17
GSCO
07/27/17
NO CHANGE
GSCO
Merck could trade up $5 following AstraZeneca MYSTIC failure, says Goldman Sachs
Goldman analyst Jami Rubin expects Merck (MRK) to trade up approximately $5 based on sentiment following AstraZeneca's MYSTIC failure as it partially de-risks longer-term estimates for Keytruda. As a result, the analyst raised Merck's Keytruda sales estimates by $600M in 2018 and $1B in 2019 and beyond, increasing earnings estimates by 14c-20c, and raising his price target on shares to $74 from $70. Rubin cautions that long-term estimates could be at risk if other competitor trials are successful. The analyst rates Merck a Neutral.

TODAY'S FREE FLY STORIES

BAC

Bank of America

$24.49

-0.94 (-3.70%)

12:40
12/10/18
12/10
12:40
12/10/18
12:40
Options
Size call spread seller returns to roll again with a Jan2020 7:1 risk/reward »

Size call spread seller…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

ENVA

Enova International

$19.80

-0.32 (-1.59%)

12:37
12/10/18
12/10
12:37
12/10/18
12:37
Conference/Events
Enova International management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

CI

Cigna

$202.13

-4.07 (-1.97%)

12:35
12/10/18
12/10
12:35
12/10/18
12:35
Options
Cigna put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

FTNT

Fortinet

$73.55

1.92 (2.68%)

12:34
12/10/18
12/10
12:34
12/10/18
12:34
Hot Stocks
Fortinet secures Indian express distribution and logistics firm DTDC Express »

Fortinet announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 13

    Dec

  • 19

    Dec

  • 10

    Jan

12:34
12/10/18
12/10
12:34
12/10/18
12:34
General news
TD Ameritrade IMX Level data reported »

November TD Ameritrade…

GOOG

Alphabet

$1,030.80

-5.72 (-0.55%)

, GOOGL

Alphabet Class A

$1,040.89

-6.1 (-0.58%)

12:34
12/10/18
12/10
12:34
12/10/18
12:34
Hot Stocks
Google to shut down Google+ four months early after second data leak »

David Thacker, VP,…

GOOG

Alphabet

$1,030.80

-5.72 (-0.55%)

GOOGL

Alphabet Class A

$1,040.89

-6.1 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 03

    Mar

PDD

Pinduoduo

$20.26

-0.34 (-1.65%)

12:25
12/10/18
12/10
12:25
12/10/18
12:25
Options
Pinduoduo call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
12/10/18
12/10
12:25
12/10/18
12:25
General news
Euro$ interest rate futures perked up »

Euro$ interest rate…

BCO

Brink's

$61.25

-0.85 (-1.37%)

12:22
12/10/18
12/10
12:22
12/10/18
12:22
Conference/Events
Brink's management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

QCOM

Qualcomm

$57.75

1.75 (3.13%)

, AAPL

Apple

$164.67

-3.7 (-2.20%)

12:20
12/10/18
12/10
12:20
12/10/18
12:20
Recommendations
Qualcomm, Apple analyst commentary  »

Injunction may be first…

QCOM

Qualcomm

$57.75

1.75 (3.13%)

AAPL

Apple

$164.67

-3.7 (-2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTRI

Nutrisystem

$44.15

9.96 (29.13%)

12:17
12/10/18
12/10
12:17
12/10/18
12:17
Downgrade
Nutrisystem rating change  »

Nutrisystem downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/10/18
12/10
12:17
12/10/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLD

TopBuild

$46.22

-0.96 (-2.03%)

12:16
12/10/18
12/10
12:16
12/10/18
12:16
Conference/Events
TopBuild management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 13

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/10/18
12/10
12:16
12/10/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$49.62

-2.44 (-4.69%)

12:15
12/10/18
12/10
12:15
12/10/18
12:15
Options
Anadarko put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

CCK

Crown Holdings

$47.82

-0.22 (-0.46%)

12:14
12/10/18
12/10
12:14
12/10/18
12:14
Conference/Events
Crown Holdings to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRDXF

Nordex

$0.00

(0.00%)

12:13
12/10/18
12/10
12:13
12/10/18
12:13
Upgrade
Nordex rating change  »

Nordex upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:10
12/10/18
12/10
12:10
12/10/18
12:10
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

KO

Coca-Cola

$48.84

-0.24 (-0.49%)

12:08
12/10/18
12/10
12:08
12/10/18
12:08
Periodicals
Coca-Cola hires broker to sell iconic Fifth Avenue building, Bloomberg says »

Coca-Cola has enlisted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 18

    Dec

  • 03

    Mar

DLAKY

Lufthansa

$0.00

(0.00%)

, EADSY

Airbus

$0.00

(0.00%)

12:07
12/10/18
12/10
12:07
12/10/18
12:07
Periodicals
Avianca CEO wants to cut Airbus order by as much as half, Reuters says »

Avianca Holdings (AVH)…

DLAKY

Lufthansa

$0.00

(0.00%)

EADSY

Airbus

$0.00

(0.00%)

AVH

Avianca

$4.91

-0.39 (-7.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$165.25

-3.12 (-1.85%)

, QCOM

Qualcomm

$58.05

2.05 (3.66%)

12:06
12/10/18
12/10
12:06
12/10/18
12:06
OnTheFly
Fly Intel: Wall Street's top stories at midday »

The averages were…

AAPL

Apple

$165.25

-3.12 (-1.85%)

QCOM

Qualcomm

$58.05

2.05 (3.66%)

FB

Facebook

$140.74

3.32 (2.42%)

GPRO

GoPro

$4.94

-0.04 (-0.80%)

TVPT

Travelport

$15.68

0.275 (1.79%)

NTRI

Nutrisystem

$44.14

9.95 (29.10%)

TVTY

Tivity Health

$28.53

-12.07 (-29.73%)

XPER

Xperi

$18.34

5.54 (43.28%)

SSNLF

Samsung

$0.00

(0.00%)

MDRX

Allscripts

$10.15

0.66 (6.95%)

MGNX

MacroGenics

$12.00

-4.44 (-27.01%)

CRZO

Carrizo Oil & Gas

$14.69

-1.2 (-7.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

  • 06

    Jan

KZR

Kezar Life Sciences

$27.79

0.41 (1.50%)

12:05
12/10/18
12/10
12:05
12/10/18
12:05
Conference/Events
Kezar Life Sciences management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

T

AT&T

$29.50

-0.64 (-2.12%)

12:05
12/10/18
12/10
12:05
12/10/18
12:05
Options
AT&T call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 20

    Mar

BC

Brunswick

$49.53

-0.05 (-0.10%)

12:02
12/10/18
12/10
12:02
12/10/18
12:02
Conference/Events
Brunswick management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

AJG

Arthur J. Gallagher

$73.87

-0.74 (-0.99%)

12:01
12/10/18
12/10
12:01
12/10/18
12:01
Hot Stocks
Arthur J. Gallagher acquires Captive Insurance Company Design and Operations »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.